Federal Inspector General Investigations

Federal Inspector General Investigations

Our seasoned team has represented dozens of companies, executives, and current and former officials in inspector general investigations.

Experience

  • Representing financial institutions in connection with several high-profile inquiries by the Special Inspector General for the Troubled Asset Relief Program and the Treasury Department Inspector General arising from the financial crisis or federal contracts.
  • Representing a government contractor in a Department of Energy Inspector General investigation into alleged retaliation against a former employee.
  • Representing an energy company in a Department of the Interior Inspector General investigation into potential conflicts of interest.
  • Representing a former senior employee at the SEC in an SEC Inspector General investigation regarding leasing issues.
  • Representing an SEC employee and a law firm partner in separate SEC Inspector General investigations.
  • Representing the subsidiary of a utility holding company in an investigation by the Inspectors General of the General Services Administration and the Small Business Administration into an alleged conspiracy to obtain federal contracts.
  • Representing a contractor for the US Agency for International Development in a Department of Justice investigation into a contract for the provision of services in Iraq following a referral from the USAID Inspector General.
  • Representing an oil and gas client in a Department of the Interior Inspector General investigation with respect to Clean Water Act issues and potential debarment.
  • Representing a senior US Postal Service official in a USPS Inspector General investigation relating to compensation issues; at the conclusion, no charges were brought against our client.
  • Representing a crop insurance company in a joint Department of Housing and Urban Development and Department of Justice Inspector General investigation into alleged False Claims Act violations in the crop insurance program.
  • Advising major pharmaceutical companies with respect to negotiations with the HHS Inspector General concerning exclusion and corporate integrity agreements in connection with resolution of False Claims Act and related allegations.

Insights & News